Search research articles
Contact Us
Filters
Showing results (91-100 of 109) with videos related to
Page
of 11
Sort By:
Blood Advances
|
September 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 11, 2014
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation
Mehdi Hamadani, Parameswaran N Hari, Ying Zhang, et al.
Transplantation and Cellular Therapy
|
October 3, 2020
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study
Nelli Bejanyan, Meijie Zhang, Khalid Bo-Subait, et al.
Blood Advances
|
May 5, 2019
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia
Rohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2020
Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT
Rohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 6, 2018
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation
Maxim Norkin, Bronwen E Shaw, Ruta Brazauskas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 12, 2020
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes
Aziz Nazha, Zhen-Huan Hu, Tao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2019
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
Haesook T Kim, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Bone Marrow Transplantation
|
March 17, 2022
Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
Antonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri, et al.
Bone Marrow Transplantation
|
September 29, 2021
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
Antonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 109) with videos related to
Sort By:
Page
of 11
Blood Advances
|
September 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 11, 2014
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation
Mehdi Hamadani, Parameswaran N Hari, Ying Zhang, et al.
Transplantation and Cellular Therapy
|
October 3, 2020
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study
Nelli Bejanyan, Meijie Zhang, Khalid Bo-Subait, et al.
Blood Advances
|
May 5, 2019
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia
Rohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2020
Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT
Rohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 6, 2018
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation
Maxim Norkin, Bronwen E Shaw, Ruta Brazauskas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 12, 2020
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes
Aziz Nazha, Zhen-Huan Hu, Tao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2019
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
Haesook T Kim, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Bone Marrow Transplantation
|
March 17, 2022
Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
Antonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri, et al.
Bone Marrow Transplantation
|
September 29, 2021
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
Antonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri, et al.
Page
of 11